MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIEBUYCK, J. F.
Right arrow Articles by LUND, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIEBUYCK, J. F.
Right arrow Articles by LUND, P.

Molecular Pharmacology, Vol 10, 474-483, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Halothane and Other Anesthetic Agents on the Concentrations of Rat Liver Metabolites in Vivo

JULIEN F. BIEBUYCK 1 and PATRICIA LUND 1

1 Metabolic Research Laboratory, Nuffield Department of Clinical Medicine, Radcliffe Infirmary, Oxford, OX2 6HE, England and Department of Anesthesia, Harvard Medical School, Massachusetts General Hospital, Boston, Mass. 02114, U.S.A.

The technique of freeze-clamping has been used to study metabolic changes occurring in the livers of rats in vivo after acute or chronic exposure to halothane (2-bromo-2-chloro-1,1,1,-trifluoroethane), an anesthetic agent in common clinical use. For comparison similar experiments were carried out with methoxyflurane, trichlorethylene, or diethyl ether. In fed animals, exposure to halothane (1.5%, v/v) for 60 min caused glycogenolysis in the liver, with a significant decrease in tissue glycogen and increase in tissue and blood glucose concentrations. These changes were accompanied by a 50% decrease in the concentrations of 2-oxoglutarate and glutamate. The oxidation-reduction states of the NAD couple in both cytoplasm and mitochondria were unaffected by halothane. One hour after withdrawal of halothane the decrease in glycogen persisted, whereas glucose returned to normal within 30 min. On repeated exposure of animals to halothane (six successive periods of anesthesia for 60 min at 48-hr intervals) the glycogenolytic response was less marked, because of glycogen stores were not replenished between periods of anesthesia. At the end of the sixth anesthesia period the levels of 2-oxoglutarate and glutamate were 25% and 40% lower, respectively, than in the unanesthetized controls. Depletion of glycogen persisted for more than 3 days, but less than 4 weeks, after repeated exposure to halothane. None of the liver metabolite changes brought about by halothane in fed rats were found in rats fasted for 24 hr or in livers from rats adapted to a high-fat diet. Glycogenolysis was a metabolic response common to all four anesthetic agents tested. Only halothane brought about decreases in 2-oxoglutarate and glutamate concentrations: a single exposure (30 min) to trichlorethylene (1%, v/v, in O2) caused a 60% increase in 2-oxoglutarate concentration over the unanesthetized control value.

Note:
ACKNOWLEDGMENTS The authors are grateful to Sir Hans Krebs and Dr. D. H. Williamson for helpful discussions. They also appreciate the skillful help of Dr. Williamson in the freeze-clamping technique, and the competent technical assistance of Mrs. Robin Roe.

Submitted on January 28, 1974




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. M. Thompson, A. M. Norman, S. S. Donkin, R. R. Shankar, M. H. Vickers, J. L. Miles, and B. H. Breier
Prenatal and Postnatal Pathways to Obesity: Different Underlying Mechanisms, Different Metabolic Outcomes
Endocrinology, May 1, 2007; 148(5): 2345 - 2354.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics